Video Experimental Relacionado
Updated: Jul 10, 2026

10:27
Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Published on: December 15, 2011
25.1K
Un caso de pseudo-reducción de IgA
Clinical laboratory
|February 11, 2026
Resumen
El efecto gancho puede causar niveles falsamente bajos de inmunoglobulina A (IgA), lo que potencialmente enmascara el mieloma múltiple. Las pruebas de dilución son cruciales para una medición y diagnóstico precisos de IgA.
Área de la Ciencia:
- Química clínica es la química clínica.
- Inmunología Inmunología.
- Medicina de diagnóstico La medicina de diagnóstico es la medicina de diagnóstico.
Sus antecedentes:
- La inmunoglobulina A (IgA) es un biomarcador clave para la función inmune y el diagnóstico del mieloma múltiple.
- El efecto gancho puede causar resultados falsamente bajos de IgA a altas concentraciones, enmascarando la enfermedad.
- Este fenómeno plantea el riesgo de un diagnóstico erróneo o un diagnóstico perdido.
Objetivo del estudio:
- Para reportar un caso de una falsa disminución de IgA debido al efecto gancho.
- Para resaltar la importancia clínica del efecto gancho en las pruebas de IgA.
- Para enfatizar la importancia de una cuantificación precisa de las IgA.
Principales métodos:
- Un estudio de caso que informa de un paciente con una falsa disminución de las IgA.
- Análisis de los niveles de IgA, IgM e IgG junto con la globulina sérica.
- Nuevo ensayo de la muestra después de la dilución en serie para determinar la verdadera concentración de IgA.
Principales resultados:
- La detección inicial de IgA fue de 6,89 g/L, significativamente menor que el nivel de globulina sérica (52,5 g/L).
- Una nueva prueba después de la dilución reveló que el verdadero valor de IgA era de 37,25 g/L.
- La discrepancia confirmó una falsa disminución de IgA causada por el efecto gancho.
Conclusiones:
- Las discrepancias entre los resultados de IgA y los niveles de globulina sérica justifican la investigación del efecto gancho.
- El personal del laboratorio debe realizar una nueva prueba de dilución para obtener niveles precisos de IgA.
- La medición precisa de IgA es esencial para prevenir el diagnóstico erróneo y el diagnóstico omitido del mieloma múltiple.
Videos de Conceptos Relacionados
Transcytosis of IgG
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Pneumonia I: Introduction
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia IV: Management
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Atypical Pneumonia
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...

